Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Differentiated PSIP table update interval technology
Device and implantation system for electrical stimulation of biological systems
Methods to fabricate a photoactive substrate suitable for microfabrication
Systems, methods, and computer readable media for providing information related to virtual environments to wireless devices
Hair care composition
Visual model importation
Drive apparatus
  Randomly Featured Patents
Clutch disk with torsional damper device
Method of sealing semiconductor device with resin by pressing a lead frame to a heat sink using an upper mold pressure member
Skin tanning composition and method
Lighter for stove, open hearth and similar
Magnifier and letter opener
Apparatus for diverting objects from a main conveyor path
Steering column supporting structure for motor vehicle
System and method for providing a wide operand architecture
Universal short code administration facility
Method of operating an internal combustion engine